Loading live market data…

Igene Biotechnology, Inc.

OTC:IGNE

$0.00001 USD

$0 (0.0%)

Volume
50.56K
Average Volume
40.69K
Market Capitalization
$15.65K
P/E Ratio
-0.10
Dividend Yield
0.00%
Price Target
$
Year High
$0.00
Year Low
$0.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.35

Industry, Sector & symbol

Stock Exchange OTC
CEO Joseph L. Downs
Industry Agricultural Inputs
Sector Basic Materials
Current Symbol IGNE
CUSIP 451695100
CIK 0000793160
Web https://www.igene.com
Phone 410-997-2599
Currency USD
Employees 18
Country US

Liquidity

Debt-to-Equity Ratio -2.48
Payout Ratio 0.00
Current Ratio 2.35
Quick Ratio 2.35
Cash Ratio 0.83

Sales & Book Value

Annual Sales $3.96M
Price / Sales 0.00
Cash Flow 0.00
Price / Cash Flow -0.06
Price / Book -0.01

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating N/A
Rating Score(0-5) 0
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0001
Trailing P/E Ratio -0.10
PEG Ratio 0.01
P/E Growth 0.01
Net Income $-140.75K
Net Margin -3.56%
Pretax Margin -1.09%
Return on Equity 5.19%
Return on Assets -2.96%

Financials Score

AltmanZ Score -22.97
Piotroski Score 1.00
Working Capital 312.11K
Total Assets 3.41M
Ebit -596.77K
Market Cap 15.65K
Total Liabilities 8.1M

Poll Results

About Igene Biotechnology, Inc. (OTC:IGNE) Stock

Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes – from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and qua ... ntifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.

Frequently Asked Questions

What is the current Igene Biotechnology, Inc. (IGNE) stock price?

Igene Biotechnology, Inc.(OTC:IGNE) stock price is $0.00001 in the last trading session. During the trading session, IGNE stock reached the peak price of $0.00001 while $0.000001 was the lowest point it dropped to. The percentage change in IGNE stock occurred in the recent session was 0.0% while the dollar amount for the price change in IGNE stock was $0.

IGNE's industry and sector of operation?

The OTC listed IGNE is part of Agricultural Inputs industry that operates in the broader Basic Materials sector.

Who are the executives of IGNE?

Joseph L. Downs | Chief Executive Officer
|
|
|
|

How many employees does IGNE have?

Number of IGNE employees currently stands at 18. IGNE operates from 9110 Red Branch Road, Columbia, MD 21045, US.

Link for IGNE official website?

Official Website of IGNE is: https://www.igene.com

How do I contact IGNE?

IGNE could be contacted at phone #410-997-2599 and can also be accessed through its website. IGNE operates from 9110 Red Branch Road, Columbia, MD 21045, US.

How many shares of IGNE are traded daily?

The average number of IGNE shares traded daily for last 3 months was 40.69K.

What is the market cap of IGNE currently?

The market value of IGNE currently stands at $15.65K with its latest stock price at $0.00001